LGND icon

Ligand Pharmaceuticals
LGND

Overview Fund Activity

298 hedge funds and large institutions have $3.35B invested in Ligand Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 123 increasing their positions, 99 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
298
Holders Change
+5
Holders Change %
+1.71%
% of All Funds
6.77%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.16%
New
36
Increased
123
Reduced
99
Closed
31
Calls
$7.11M
Puts
$18.2M
Net Calls
-$11.1M
Net Calls Change
-$3.05M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$21.9M
2
State Street
State Street
Massachusetts
+$15.8M
3
O
OppenheimerFunds
New York
+$14.7M
4
William Blair Investment Management
William Blair Investment Management
Illinois
+$12.7M
5
GT
Glenmede Trust
Pennsylvania
+$11M

Top Sellers

1
Bank of America
Bank of America
North Carolina
-$61M
2
Victory Capital Management
Victory Capital Management
Texas
-$18.3M
3
ORI
Oak Ridge Investments
Illinois
-$15.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$14M
5
Macquarie Group
Macquarie Group
Australia
-$12.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
FPFS
326
First Personal Financial Services
North Carolina
– -$8K -93 Closed
GEA
327
Glen Eagle Advisors
New Jersey
– -$4.09K -48 Closed
LWCFA
328
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$1K -13 Closed
10 11 12 13
14